Cargando…
Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy
Chronic Pseudomonas aeruginosa lung infections in cystic fibrosis (CF) evolve to generate environmentally adapted biofilm communities, leading to increased patient morbidity and mortality. OligoG CF-5/20, a low-molecular-weight inhaled alginate oligomer therapy, is currently in phase IIb/III clinica...
Autores principales: | Oakley, Juliette L., Weiser, Rebecca, Powell, Lydia C., Forton, Julian, Mahenthiralingam, Eshwar, Rye, Philip D., Hill, Katja E., Thomas, David W., Pritchard, Manon F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845618/ https://www.ncbi.nlm.nih.gov/pubmed/33472983 http://dx.doi.org/10.1128/mSphere.01216-20 |
Ejemplares similares
-
Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides
por: Powell, Lydia C., et al.
Publicado: (2018) -
Structure–Activity Relationships of Low Molecular Weight Alginate Oligosaccharide Therapy against Pseudomonas aeruginosa
por: Pritchard, Manon F., et al.
Publicado: (2023) -
Alginate oligosaccharides enhance the antifungal activity of nystatin against candidal biofilms
por: Powell, Lydia C., et al.
Publicado: (2023) -
The antimicrobial effects of the alginate oligomer OligoG CF-5/20 are independent of direct bacterial cell membrane disruption
por: Pritchard, Manon F., et al.
Publicado: (2017) -
Characterization of different alginate lyases for dissolving Pseudomonas aeruginosa biofilms
por: Blanco-Cabra, Núria, et al.
Publicado: (2020)